76
Participants
Start Date
August 30, 2018
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
DaTscan
A functional imaging of the dopamine transporter using the radioligand \[123I\]FP-CIT
F18-AV-45
A brain scan to to measure the extent of amyloid deposition
FDG-PET
a brain scan measuring total and regional cerebral glucose metabolism wtih positron emission tomographs with 2-(18F)
APOE genotype
10 ml of whole blood will be drawn and shipped to Athena Diagnostics for genetic testing.
Polysomnogram
Overnight sleep study
Clinical Assessment
Clinical assessments include cognitive, behavioral, and motor evaluations
RECRUITING
The Ohio State University, Columbus
Collaborators (2)
Avid Radiopharmaceuticals
INDUSTRY
Mangurian Foundation
UNKNOWN
Douglas Scharre
OTHER